Influence of exogenous glucagon on fetal glucose metabolism and ketone production

Anthony F Philipps, J. W. Dubin, P. J. Matty, J. R. Raye

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Acute glucagon injections were performed in chronically catheterized fetal lambs in late gestation to assess the fetal metabolic response to exogenous glucagon infusion. Glucagon dosages between 1 μg/kg and 1 mg/kg induced significantly fetal hyperglycemia by 15-30 min postinjection, with peak glucose values 130-180% of control. Increasing responsivity to the same dose/kg was noted to parallel increasing gestational age. In selected preparations in which umbilical venous catheters were implanted, glucagon injection caused an acute fall in the glucose/oxygen quotient and net umbilical glucose consumption. The fall in glucose consumption to 8% of control values occurred within 15 min of injection and suggests acute fetal glucose excretion, probably secondary to hepatic glycogenolysis. Glucagon injection in the neonatal lamb caused qualitatively similar increases in plasma glucose concentration but the quantitative responses were considerably greater. No change in fetal β-hydroxybutyrate (β-OHB) concentration was noted after injection; nor did the fetal uptake or excretion of this ketone change. The neonatal β-OHB concentration was significantly different (P < 0.001) from fetal concentrations and did rise 14% above control after glucagon injection; thus, elevation of plasma glucagon in the fetus causes an acute hyperglycemia but, unlike the adult, does not induce a significant ketogenesis.

Original languageEnglish (US)
Pages (from-to)51-56
Number of pages6
JournalPediatric Research
Volume17
Issue number1
StatePublished - 1983
Externally publishedYes

Fingerprint

Ketones
Glucagon
Glucose
Injections
Umbilicus
Hyperglycemia
Hydroxybutyrates
Glycogenolysis
Gestational Age
Fetus
Catheters
Oxygen
Pregnancy
Liver

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Influence of exogenous glucagon on fetal glucose metabolism and ketone production. / Philipps, Anthony F; Dubin, J. W.; Matty, P. J.; Raye, J. R.

In: Pediatric Research, Vol. 17, No. 1, 1983, p. 51-56.

Research output: Contribution to journalArticle

Philipps, Anthony F ; Dubin, J. W. ; Matty, P. J. ; Raye, J. R. / Influence of exogenous glucagon on fetal glucose metabolism and ketone production. In: Pediatric Research. 1983 ; Vol. 17, No. 1. pp. 51-56.
@article{d640ed7651bc47e48bc9b6509c98e638,
title = "Influence of exogenous glucagon on fetal glucose metabolism and ketone production",
abstract = "Acute glucagon injections were performed in chronically catheterized fetal lambs in late gestation to assess the fetal metabolic response to exogenous glucagon infusion. Glucagon dosages between 1 μg/kg and 1 mg/kg induced significantly fetal hyperglycemia by 15-30 min postinjection, with peak glucose values 130-180{\%} of control. Increasing responsivity to the same dose/kg was noted to parallel increasing gestational age. In selected preparations in which umbilical venous catheters were implanted, glucagon injection caused an acute fall in the glucose/oxygen quotient and net umbilical glucose consumption. The fall in glucose consumption to 8{\%} of control values occurred within 15 min of injection and suggests acute fetal glucose excretion, probably secondary to hepatic glycogenolysis. Glucagon injection in the neonatal lamb caused qualitatively similar increases in plasma glucose concentration but the quantitative responses were considerably greater. No change in fetal β-hydroxybutyrate (β-OHB) concentration was noted after injection; nor did the fetal uptake or excretion of this ketone change. The neonatal β-OHB concentration was significantly different (P < 0.001) from fetal concentrations and did rise 14{\%} above control after glucagon injection; thus, elevation of plasma glucagon in the fetus causes an acute hyperglycemia but, unlike the adult, does not induce a significant ketogenesis.",
author = "Philipps, {Anthony F} and Dubin, {J. W.} and Matty, {P. J.} and Raye, {J. R.}",
year = "1983",
language = "English (US)",
volume = "17",
pages = "51--56",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Influence of exogenous glucagon on fetal glucose metabolism and ketone production

AU - Philipps, Anthony F

AU - Dubin, J. W.

AU - Matty, P. J.

AU - Raye, J. R.

PY - 1983

Y1 - 1983

N2 - Acute glucagon injections were performed in chronically catheterized fetal lambs in late gestation to assess the fetal metabolic response to exogenous glucagon infusion. Glucagon dosages between 1 μg/kg and 1 mg/kg induced significantly fetal hyperglycemia by 15-30 min postinjection, with peak glucose values 130-180% of control. Increasing responsivity to the same dose/kg was noted to parallel increasing gestational age. In selected preparations in which umbilical venous catheters were implanted, glucagon injection caused an acute fall in the glucose/oxygen quotient and net umbilical glucose consumption. The fall in glucose consumption to 8% of control values occurred within 15 min of injection and suggests acute fetal glucose excretion, probably secondary to hepatic glycogenolysis. Glucagon injection in the neonatal lamb caused qualitatively similar increases in plasma glucose concentration but the quantitative responses were considerably greater. No change in fetal β-hydroxybutyrate (β-OHB) concentration was noted after injection; nor did the fetal uptake or excretion of this ketone change. The neonatal β-OHB concentration was significantly different (P < 0.001) from fetal concentrations and did rise 14% above control after glucagon injection; thus, elevation of plasma glucagon in the fetus causes an acute hyperglycemia but, unlike the adult, does not induce a significant ketogenesis.

AB - Acute glucagon injections were performed in chronically catheterized fetal lambs in late gestation to assess the fetal metabolic response to exogenous glucagon infusion. Glucagon dosages between 1 μg/kg and 1 mg/kg induced significantly fetal hyperglycemia by 15-30 min postinjection, with peak glucose values 130-180% of control. Increasing responsivity to the same dose/kg was noted to parallel increasing gestational age. In selected preparations in which umbilical venous catheters were implanted, glucagon injection caused an acute fall in the glucose/oxygen quotient and net umbilical glucose consumption. The fall in glucose consumption to 8% of control values occurred within 15 min of injection and suggests acute fetal glucose excretion, probably secondary to hepatic glycogenolysis. Glucagon injection in the neonatal lamb caused qualitatively similar increases in plasma glucose concentration but the quantitative responses were considerably greater. No change in fetal β-hydroxybutyrate (β-OHB) concentration was noted after injection; nor did the fetal uptake or excretion of this ketone change. The neonatal β-OHB concentration was significantly different (P < 0.001) from fetal concentrations and did rise 14% above control after glucagon injection; thus, elevation of plasma glucagon in the fetus causes an acute hyperglycemia but, unlike the adult, does not induce a significant ketogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0020676821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020676821&partnerID=8YFLogxK

M3 - Article

C2 - 6835715

AN - SCOPUS:0020676821

VL - 17

SP - 51

EP - 56

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -